Search clinical trials for: Atezolizumab Injection [Tecentriq]
Total 10552 results
-
NeoImmuneTechImmune Oncology NetworkTerminatedMelanoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
The Methodist Hospital Research InstituteGenentech, Inc.Recruiting
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
Fundacion Espanola para la Curacion de la Leucemia...Pfizer; Roche Farma, S.ATerminatedChronic Phase-Chronic Myeloid LeukemiaSpain
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
Gruppo Oncologico Italiano di Ricerca ClinicaRecruitingMesotheliomas PleuralItaly
-
Hoffmann-La RocheRecruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Nykode Therapeutics ASARoche Pharma AG; Vaccibody ASCompletedCervical Cancer | Cervix CancerBelgium, Germany, Bulgaria, Czechia, Norway, Poland
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingMelanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Colorectal Neoplasms | Endometrial Neoplasms | Malignant Neoplasm | MalignancyUnited Kingdom
-
AIO-Studien-gGmbHRoche Pharma AG; Immodulon Therapeutics LtdRecruiting
-
Oncology Institute of Southern SwitzerlandEnte Ospedaliero Cantonale, Bellinzona; Clinical Trial Unit Ente Ospedaliero... and other collaboratorsActive, not recruitingNSCLC Stage IVSwitzerland
-
European Organisation for Research and Treatment...Hoffmann-La RocheTerminatedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary SyndromeSpain, Switzerland
-
Liza Villaruz, MDGenentech, Inc.CompletedAdvanced Non-small Cell Lung CancerUnited States
-
Jun Zhang, MD, PhDGenentech, Inc.; ExelixisNot yet recruitingLung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
British Columbia Cancer AgencyHoffmann-La RocheRecruitingSarcoma | Breast Cancer | Head and Neck Cancer | Gynecologic Cancer | Lung Cancer | Skin Cancer | Gastrointestinal Cancer | Unknown Primary Tumors | Genitourinary CancerCanada
-
Hoffmann-La RocheCompleted
-
Nykode Therapeutics ASAGenentech, Inc.; Vaccibody ASActive, not recruitingSolid Tumors, AdultSpain, United States, Germany
-
Norwegian University of Science and TechnologyVestre Viken Hospital Trust; Odense University Hospital; Karolinska University... and other collaboratorsActive, not recruitingSmall-cell Lung CancerNetherlands, Switzerland, Denmark, Sweden, Norway, Lithuania
-
Hoffmann-La RocheCompletedLymphoma, FollicularFrance, United States
-
Instituto Oncológico Dr RosellRoche Pharma AG; Fundacion Clinic per a la Recerca BiomédicaActive, not recruitingExtensive-stage Small Cell Lung CancerSpain
-
University of Michigan Rogel Cancer CenterWithdrawnProstate CancerUnited States
-
Ronald BuckanovichGenentech, Inc.RecruitingPARP Inhibitor | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Hedgehog InhibitorUnited States
-
M.D. Anderson Cancer CenterRecruitingMetastatic MalignancyUnited States
-
Hoffmann-La RocheExelixis; ChugaiActive, not recruitingCarcinoma, Renal CellUnited States, Korea, Republic of, France, Denmark, Italy, Poland, Spain, Japan, Canada, Argentina, United Kingdom, Russian Federation, Australia, Germany, Greece
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Eikon TherapeuticsSeven and Eight Biopharmaceuticals IncActive, not recruitingTumor, SolidUnited States
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Hoffmann-La RocheActive, not recruitingSmall Cell Lung Cancer | Hepatocellular Carcinoma | Non-Small Cell Lung Cancer | Urothelial CarcinomaHungary, United Kingdom, Belgium, Croatia, France, Italy, Spain, United Arab Emirates, Argentina, Bulgaria, Poland, Philippines, Serbia, Netherlands, Romania, Colombia, Austria, Russian Federation, Singapore, Estonia, Egypt, India, ... and more
-
Centre Georges Francois LeclercRecruitingMetastatic Renal Cell Carcinoma | Metastatic Non Small Cell Lung Cancer | Metastatic Head and Neck Cancer | Metastatic Bladder CancerFrance
-
Institut für Klinische Krebsforschung IKF GmbH...RecruitingIntrahepatic CholangiocarcinomaGermany
-
Deepak KilariGenentech, Inc.; Medical College of Wisconsin; ExelixisRecruitingBladder CancerUnited States
-
Genentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, France, Serbia
-
Washington University School of MedicineGenentech, Inc.Terminated
-
Rain Oncology IncWithdrawnMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossMelanoma | Renal Cell Carcinoma | Gastric Cancer | NSCLC | Mesothelioma | Advanced Solid Tumor | Pancreas Adenocarcinoma | Urothelial Carcinoma Bladder | HNSCC | CDKN2A
-
Gradalis, Inc.Roche-GenentechCompletedCervical Cancer | Ovarian Cancer | Uterine Cancer | Advanced Gynecological CancersUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
Niguarda HospitalActive, not recruitingCLL TransformationItaly, Switzerland
-
Hoffmann-La RocheActive, not recruitingSolid TumorsBelgium, Denmark, Spain, Canada, Netherlands, Poland
-
Hoffmann-La RocheActive, not recruitingCervical CancerItaly, Korea, Republic of, Canada, United States, Brazil, France, United Kingdom, Spain, Costa Rica, Russian Federation, Panama, Australia, Mexico, Peru, Poland, Taiwan, Thailand
-
Immunocore LtdTerminatedSelect Advanced Solid TumorsUnited States, United Kingdom, Spain
-
Alliance Foundation Trials, LLC.Genentech, Inc.Recruiting
-
invoX Pharma LimitedRecruitingMelanoma | Solid Tumor | Head and Neck Squamous Cell CarcinomaUnited States
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerSpain, Argentina, China, France, Turkey, Brazil, Korea, Republic of, Mexico, Chile, Guatemala, Peru, Thailand, Costa Rica, United Kingdom, New Zealand, Hungary, Latvia, Russian Federation, South Africa, Ukraine, Italy, Greece, Poland
-
Dana-Farber Cancer InstituteEli Lilly and Company; Genentech, Inc.Active, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Hoffmann-La RocheTerminatedCarcinoma, Small Cell LungChina
-
Hoffmann-La RocheTerminatedCarcinoma, Transitional CellUnited States, Korea, Republic of, France, United Kingdom, Belgium, Canada, China, Greece, Spain, Turkey, Japan, Czechia, Israel, Italy, Russian Federation, Poland, Switzerland, Australia, Germany, Netherlands, Taiwan, Ukraine, Serbia, Finla...